Covered by insurance in all 50 states, incl. Medicare Advantage day one
Back to Blog

Latuda Side Effects: Akathisia, Nausea, and the Food Rule

Clinically reviewed by Daniel Montville, MD

Reviewed October 21, 2026 · Last updated September 30, 2026

Key Takeaways

  • In the adult bipolar depression trial, the most common Latuda side effects were nausea, akathisia (inner restlessness), sleepiness, and movement symptoms, and all of them were more frequent at 80 to 120 mg than at 20 to 60 mg.
  • Akathisia usually shows up within days of starting or raising the dose. A Canadian guideline recommends trying a lower dose or a switch first, with propranolol as the first-choice add-on if needed.
  • Latuda must be taken with at least 350 calories, which roughly doubles total absorption. Skipping food makes your real dose swing from day to day.
  • Latuda ranks among the most metabolically gentle antipsychotics. Average weight gain in its trials was well under a pound more than placebo, though weight, blood sugar, and lipids still need checking.

You started Latuda to lift a heavy bipolar depression, and a few days in, your legs won’t stay still. You pace the kitchen at night, and sitting through a meeting feels like holding your breath. Or maybe it’s a queasy stomach that shows up after every dose. Both are common with Latuda, both are tied to dose, and both have real fixes.

Latuda (lurasidone) works mainly by blocking dopamine D2 and serotonin 5-HT2A receptors, according to the Latuda prescribing information. Blocking dopamine in the brain circuits that control movement with precision is thought to underlie the restlessness, tremor, and stiffness some people feel.

The standard way to judge Latuda’s side effects is the label’s clinical trial data, which compares each dose range with placebo over six weeks. Those trials led to FDA approval for bipolar depression and schizophrenia, and they give honest numbers for what people experienced. The data are real, and the label is where any careful conversation starts.

But most side effect summaries quote the schizophrenia trials, which used higher doses than most people take for bipolar depression, and at Siggy we’d rather match the numbers to your situation. This guide uses the bipolar depression data first, then explains what akathisia feels like, how it’s treated, why the food rule matters, and how Latuda’s metabolic profile compares with other antipsychotics. Knowing which side effects follow your dose makes each decision grounded in pharmacology.

What This Page Covers

What Are the Most Common Latuda Side Effects?

In the adult bipolar depression trial of Latuda on its own, people were randomly assigned to 20 to 60 mg, 80 to 120 mg, or placebo for six weeks. Here’s how often the most common side effects showed up, rounded as in the label:

Side Effect 20 to 60 mg 80 to 120 mg Placebo
Nausea 10% 17% 8%
Akathisia 8% 11% 2%
Sleepiness 7% 14% 7%
Movement symptoms 5% 9% 2%

Two patterns stand out. Every one of these side effects was more common at the higher dose range, and the label notes that 80 to 120 mg didn’t work better on average than 20 to 60 mg in that trial. Only 6% of people on Latuda stopped because of side effects, compared with 5% on placebo.

Doses for schizophrenia run higher, up to 160 mg, and so do the side effect rates. In those trials, akathisia climbed from about 6% at 20 mg to 22% at 120 mg. If you’re reading a side effect number online, check which condition and dose it came from.

What Does Latuda Akathisia Feel Like?

Akathisia is an inner restlessness that makes it hard to stay still. A Canadian clinical guideline on akathisia describes its core as a feeling of mental unease and dysphoria, sometimes strong enough to drive impulsive behavior. The restlessness is both felt and visible, and it can look like constant fidgeting or pacing.

Timing is a clue. The guideline notes that acute akathisia tends to appear within hours or days of starting an antipsychotic, and that the risk is higher in people taking one for the first time or whose dose goes up quickly. With Latuda, the label shows akathisia rising with dose.

Akathisia is easy to mistake for anxiety, agitation, or a worsening of the illness itself. That matters, because the fix is different. The guideline also notes akathisia has been linked with suicidal thinking in some groups, though how much it raises that risk is uncertain.

If you feel a new, driven restlessness after starting Latuda or raising the dose, tell your prescriber promptly rather than pushing through. If the restlessness comes with thoughts of suicide, call or text 988.

How Is Akathisia Treated?

The first moves involve Latuda itself. The Canadian guideline recommends considering a lower dose, avoiding a second antipsychotic, or switching to a different medication before adding anything new. Because Latuda’s akathisia is dose-related, a step down is often the simplest place to start.

When an add-on is needed, several options have trial support:

  • Propranolol: the guideline calls it the first-choice add-on, after checking whether it’s safe for you.
  • Mirtazapine: a low dose is an option when propranolol isn’t suitable, especially if longer-term treatment is expected.
  • Vitamin B6: high-dose B6 has shown benefit in short trials.

A 2024 network meta-analysis of 15 trials with 492 participants found mirtazapine, vitamin B6, and propranolol, among others, reduced akathisia more than placebo. The trials were small and short, and the guideline suggests giving an add-on at least 5 days before judging it. These are prescriber decisions, not self-treatment, since each option has its own risks.

Nausea and the 350-Calorie Food Rule

Nausea is one of Latuda’s most common side effects, and like akathisia, it tracks with dose. In the bipolar depression trial, it rose from 10% at the lower dose range to 17% at the higher one.

Food is where Latuda differs from most psychiatric medications. The label requires taking it with at least 350 calories, because food raises total absorption about twofold and peak levels about threefold. A food effect study found meals from 350 to 1,000 calories produced similar exposure regardless of fat content, so a modest meal is enough.

The food rule exists for absorption, and the label doesn’t claim it prevents nausea. Many people pair their dose with dinner, and a review of lurasidone coauthored by a scientist at its U.S. marketer recommends evening dosing with a meal, without claiming it’s proven to cause fewer side effects. But the food rule does matter for side effects in a practical way: if you take Latuda with dinner some nights and on an empty stomach others, the amount reaching your bloodstream can swing widely. That makes side effects, and benefits, harder to judge. Our Latuda dosage guide explains the food data in detail.

What tends to help with nausea, with your prescriber’s input:

  • Take every dose with a real meal of at least 350 calories
  • Keep the timing consistent from day to day
  • Ask whether a lower dose makes sense, since nausea rose with dose in trials
  • Tell your prescriber if nausea turns into vomiting or keeps you from eating

Sleepiness and Movement Side Effects

Sleepiness, which the label groups with sedation and oversleeping, affected 7% on the lower dose range and 14% on the higher one, compared with 7% on placebo. The label advises caution with driving or machinery until you know how Latuda affects you.

Movement side effects, which doctors call extrapyramidal symptoms, include tremor, muscle stiffness, and slowed movement. In the bipolar trial, they affected 5% on the lower dose range and 9% on the higher one. A less common form, dystonia, causes sudden muscle spasms of the neck, jaw, or eyes, and the label notes it tends to appear in the first few days of treatment. Report any new stiffness, tremor, or spasms, since dose changes often help.

Does Latuda Cause Weight Gain?

For most people, not much. In the adult bipolar depression trial, average weight change was +0.29 kg on Latuda versus -0.04 kg on placebo, and 2.4% gained 7% or more of their body weight, compared with 0.7% on placebo. In schizophrenia trials, Latuda averaged +0.43 kg, while comparison groups in two of those trials gained 4.15 kg on olanzapine and 2.09 kg on extended-release quetiapine.

Larger comparisons back that up. A network meta-analysis of 18 antipsychotics, covering 100 trials and nearly 26,000 patients, ranked lurasidone among the most metabolically benign options, alongside aripiprazole, brexpiprazole, cariprazine, and ziprasidone, with the lowest glucose change of the group. A 32-drug network meta-analysis also found lurasidone had the smallest effect on the heart’s QTc interval.

Gentle isn’t the same as zero. The label still calls for monitoring weight, blood sugar, and cholesterol, and in a two-year open-label study of children and teens, 12% of those with normal cholesterol at the start moved into the high range. Prolactin rose modestly on average, more at higher doses and in women, which can occasionally affect periods or breast tissue.

Abilify sits in the same low-metabolic group, and our guide to tracking Abilify side effects month by month shows how its profile compares.

Serious Risks and Drug Interactions

The label lists several serious but uncommon risks:

  • Boxed warnings: an increased risk of death in older adults with dementia-related psychosis, for which Latuda isn’t approved, and an increased risk of suicidal thoughts in children and young adults.
  • Neuroleptic malignant syndrome: a rare reaction with high fever, muscle rigidity, confusion, and unstable heart rate or blood pressure.
  • Tardive dyskinesia: involuntary movements, often of the face or tongue, that can become permanent and are thought to become more likely with longer treatment.
  • Mood switching: fewer than 1% of adults in the bipolar depression trials developed mania or hypomania, on Latuda or placebo.
  • Dizziness on standing: this is most likely early in treatment and during dose increases.

Interactions matter more than usual, because Latuda is broken down by the liver enzyme CYP3A4. The label says it shouldn’t be combined with strong CYP3A4 blockers, such as ketoconazole or clarithromycin, or strong inducers, such as rifampin, carbamazepine, or St. John’s wort. Moderate blockers like diltiazem call for cutting the dose in half, and grapefruit juice should be avoided.

Call 911 for a high fever with stiff muscles and confusion, or for swelling of the face, tongue, or throat. If you have thoughts of suicide, call or text 988. Don’t stop Latuda abruptly without talking to your prescriber.

Akathisia is exactly the kind of side effect that shouldn’t wait months for a check-in.

Latuda’s side effects follow a clear logic: restlessness, nausea, and sleepiness rise with dose, the food rule keeps your real dose steady, and its metabolic profile is among the gentlest in its class. Akathisia is the one to take most seriously, and it usually responds to a lower dose or a targeted add-on. If you’re weighing how bipolar depression differs from other depression, our guide to bipolar depression vs. depression is a good next read.

Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.

This article is for education only and isn’t a substitute for personal medical advice. Don’t change or stop a medication without talking to your prescriber, except in an emergency described here. It was reviewed for clinical accuracy and reflects sources available as of September 2026.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

What are the most common side effects of Latuda?

In the adult bipolar depression trial, the most common Latuda side effects were nausea, akathisia (an inner restlessness and urge to move), sleepiness, and movement symptoms like tremor or stiffness. At 20 to 60 mg a day, each affected roughly 5% to 10% of people, and rates were higher at 80 to 120 mg. In schizophrenia trials, which used higher doses, akathisia reached 22% at 120 mg.

Does Latuda akathisia go away?

Akathisia often improves when the dose is lowered, and a Canadian clinical guideline recommends dose reduction or a switch as the first steps. If it continues, add-on medications such as propranolol, mirtazapine, or vitamin B6 have trial evidence. Don't wait it out or stop Latuda on your own. Tell your prescriber, especially if the restlessness feels unbearable or comes with dark thoughts.

What happens if you take Latuda without food?

Without food, you absorb much less of your dose. The FDA label says taking Latuda with food increases total exposure about twofold and peak levels about threefold, and it calls for at least 350 calories with each dose. Regularly skipping the meal can make Latuda seem less effective and makes its effects less predictable from day to day.

Does Latuda cause weight gain?

Latuda causes little weight gain for most people compared with many other antipsychotics. In the adult bipolar depression trial, average weight gain was 0.29 kg versus a slight loss on placebo, and a large network meta-analysis ranked lurasidone among the most metabolically benign antipsychotics. Some people still gain weight, so your prescriber should track weight, blood sugar, and lipids.

Is Latuda better tolerated at night?

Many people take Latuda with dinner. The U.S. label only requires that it be taken with at least 350 calories and doesn't set a time of day. A review coauthored by the manufacturer's scientist recommends evening dosing with a meal and notes the bipolar depression trials dosed at night, though it doesn't claim evening dosing is proven to cause fewer side effects.

When is a Latuda side effect an emergency?

Call 911 for a high fever with stiff muscles and confusion, which can signal neuroleptic malignant syndrome, or for swelling of the face, tongue, or throat. Call or text 988 if you have thoughts of suicide. New involuntary movements of the face or tongue, fainting, or severe restlessness should be reported to your prescriber right away.

Sources

  1. Sumitomo Pharma America, Inc. LATUDA (lurasidone hydrochloride) tablets prescribing information. DailyMed, U.S. National Library of Medicine. Revised January 2025. dailymed.nlm.nih.gov
  2. Pringsheim T, Gardner D, Addington D, et al. The assessment and treatment of antipsychotic-induced akathisia. Canadian Journal of Psychiatry. 2018;63(11):719-729. doi:10.1177/0706743718760288
  3. Gérolymos C, Barazer R, Yon DK, et al. Drug efficacy in the treatment of antipsychotic-induced akathisia: a systematic review and network meta-analysis. JAMA Network Open. 2024;7(3):e241527. doi:10.1001/jamanetworkopen.2024.1527
  4. Preskorn S, Ereshefsky L, Chiu YY, Poola N, Loebel A. Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies. Human Psychopharmacology. 2013;28(5):495-505. doi:10.1002/hup.2338
  5. Loebel A, Citrome L. Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression. BJPsych Bulletin. 2015;39(5):237-241. doi:10.1192/pb.bp.114.048793
  6. Pillinger T, McCutcheon RA, Vano L, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. The Lancet Psychiatry. 2020;7(1):64-77. doi:10.1016/S2215-0366(19)30416-X
  7. Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. The Lancet. 2019;394(10202):939-951. doi:10.1016/S0140-6736(19)31135-3